How much funding has Antarka raised?

Antarka has raised $600K in total funding, most recently a Seed round.

Who are Antarka's investors?

Antarka's investors include SOSV, IndieBio.

Where is Antarka headquartered?

Antarka is headquartered in Montevideo, Uruguay.

What industry is Antarka in?

Antarka operates in Biotech, Cosmetics.

Antarka

Montevideo, Uruguay · Founded 2023 · $600K raised

Biotech

Cosmetics

Headquarters: Montevideo
Employees: 1–10
Founded: 2023
Website: antarka.bio

Total Funding: $600K
Last Round: $600K SeedJan 2023
Rounds: 1

About

Antarka is a Uruguayan biotechnology startup developing skin DNA-repair enzymes for cosmetic and skincare applications. Its flagship active, ANKros-CPD, is a CPD-photolyase enzyme sourced from UV-resistant Antarctic extremophile bacteria that recognizes and repairs UV-induced DNA damage in skin at the molecular level. Spun out of research at Uruguay's Universidad de la República, Antarka supplies the skin-permeable active ingredient to cosmetic brands for formulation into longevity and sun-care products.

Summary

Antarka is a Biotech company based in Montevideo, Uruguay, founded in 2023. It has raised $600K in total across 1 round, most recently a $600K Seed round in Jan 2023. Investors include SOSV and IndieBio.